Geist Wyatt D. 4

What Happened

• Wyatt D. Geist, Chief Innovation Officer of Tenon Medical, is reported to have acquired an indirect interest in 136,401 shares of Tenon Medical common stock on May 1, 2026. The transaction is coded as an award/grant (A) and the reported acquisition price is $0.00 (total $0).
• This was not an open-market purchase or sale by Geist; the shares arose from a milestone issuance to SiVantage under an Asset Purchase Agreement, and Geist’s interest reflects his equity stake in SiVantage rather than a direct issuance to him.

Key Details

• Transaction date: 2026-05-01; Form 4 filed: 2026-05-05 (Period of Report: 2026-05-01).
• Transaction type/code: Award/Grant (A); price per share: $0.00; shares reported: 136,401.
• Shares owned following the transaction: Not specified in the filing.
• Footnote summary: Tenon issued 276,228 shares to SiVantage, Inc. as a milestone payment; Geist reports an indirect pecuniary interest equal to his 49.38% equity stake in SiVantage (49.38% of 276,228 ≈ 136,401). Geist disclaims beneficial ownership except to the extent of that pecuniary interest.
• No 10b5-1 plan, tax-withholding, or late-filing flag is indicated in the provided filing details.

Context

• These shares were issued to a company (SiVantage) as part of an asset purchase milestone; Geist’s reported position is indirect, tied to his ownership in that company. This is different from a personal open-market buy or sale and should be interpreted as an ownership change tied to a corporate milestone rather than a direct insider market signal.